Meryem
Grabski

  • University College London
  • United Kingdom
In programme
  • October 23 15:40 to 15:55
  • October 24 15:10 to 15:25
View hours & dates

About

Meryem Grabski (PhD) is a research associate at the Clinical Psychopharmacology Unit at UCL. Her main research interests are the development of treatments for substance use as well as research on drug use pathways that might ultimately inform policy, for both licit and illicit substances. She is currently working on the ALAMA project as well as KARE, a clinical trial investigating the use ketamine as a possible treatment for alcoholism. She received her PhD on the effect of smoking abstinence on cognitive performance and craving from the University of Bristol in 2017.

Hours & Dates

  • Plenary session
  • Poster session
  • Big debate
  • Structured session
  • Workshop
  • Oral presentation session
  • Short communication session
  • Poster guided tour

Wednesday, 23 October

15:40
Oral presentation

Associations of ketamine use with mental health and substance use outcomes at 12 months follow-up in young Europeans

15:40 to 15:55
Networking zone 1 (N1)
Meryem Grabski

Thursday, 24 October

15:10
Oral presentation

‘EMSS Nightlife survey’: design and snapshot of findings in 5 European countries

15:10 to 15:25
Networking zone 1 (N1)
Meryem Grabski
View all speakers